Literature DB >> 169260

Reversibility of adenosine 3':5'-monophosphate-dependent protein kinase reactions.

Y Shizuta, J A Beavo, P J Bechtel, F Hofmann, E G Krebs.   

Abstract

Using a homogeneous enzyme from rabbit skeletal muscle, it has been demonstrated that the cyclic adenosine 3':5'-monophosphate (cyclic AMP)-dependent protein kinase reaction is reversible. In addition to the phosphorylated protein substrate, the reverse reaction requires Mg2+, ADP, and cyclic AMP when the holoenzyme is used as the source of enzyme. It is independent of cyclic AMP when the catalytic subunit of the protein kinase is used. The optimum pH for the reverse reaction with 32P-labeled casein as the substrate is 5.7, essentially the same as that for the forward reaction. Among the nucleotide subtrates tested, ADP serves as the best phosphoryl group acceptor. The Km of the enzyme for ADP is 3.3 mM and that for 32P-casein is 1.7 mg/ml. The equilibrium constant at 30 degrees is approximately 0.042 at a magnesium concentration of 10 mM and a pH of 6.9. This result indicates that the free energy of hydrolysis (deltaG0obs) of the phosphorylated protein substrate is relatively high, i.e. approximately -6.5 kcal/mol under these conditions.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 169260

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  Exogenous substrate stimulates autodephosphorylation of cyclic-AMP-dependent protein kinase II.

Authors:  B T Gjertsen; B Fauske; S O Døskeland
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

2.  The role of metarhodopsin in the generation of spontaneous quantum bumps in ultraviolet receptors of Limulus median eye. Evidence for reverse reactions into an active state.

Authors:  J Lisman
Journal:  J Gen Physiol       Date:  1985-02       Impact factor: 4.086

3.  Phosphorylation and Dephosphorylation of Tau Protein by the Catalytic Subunit of PKA, as Probed by Electrophoretic Mobility Retard.

Authors:  María J Benítez; Raquel Cuadros; Juan S Jiménez
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.